Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05031-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Xingdong Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450052, China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Triterpenes. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Anhui Chest Hospital Institutional Research Projects, National Natural Science Foundation of China, Cultivation Project of Henan Health Science and Technology Innovation Talents.
Abstract (Originalsprache)
Myocardial ischemia/reperfusion injury (MI/RI) is a complex state involving numerous inflammatory mediators, which significantly worsens the outcomes of patients with cardiovascular diseases. However, no standardized treatment plan for MI/RI prevails at present. Cucurbitacin B (Cb-B) is a natural bioactive substance extracted from the stem of melon flowers, and is associated with Wnt-β-Catenin, NF-κB, and PI3K/AKT signaling pathways to initiate apoptosis and inflammatory responses in various cancers. Nevertheless, its potential preventive role in MI/RI remains unclear. Here, the potential mechanism adopted by Cb-B for alleviating MI/RI was explored by network pharmacology and in vivo experiments. Firstly, network pharmacology methods, including multiple data retrieval, network construction analysis, gene ontology enrichment analysis, pathway analysis, and molecular docking, were employed to identify the target genes, signaling pathways, and potential mechanisms of Cb-B in the possible treatment of MI/RI. Simultaneously, results were validated through in vivo experiments. The results showed that the comprehensive network pharmacology identified cellular pyroptosis and apoptosis-related genes as nlrp3, caspase1, bcl-2, and caspase3. Functional enrichment analysis showed the association of these target genes with inflammatory response, positive regulation of cytokine production, and response to lipopolysaccharides in biological processes. In addition, the MI/RI rat model showed that Cb-B could alleviate myocardial injury by reducing the release of cellular pyroptosis and apoptosis-related genes. These results suggested that the mechanism of cardioprotective effects of Cb-B may be related to the regulation of PTEN/PI3K/AKT signaling pathways, which lays a foundation for further research on MI/RI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450052, China.
- Department of Cardiology, Anhui Chest Hospital, Hefei, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of University of Science and Technology of China (USTC), University of Science and Technology of China, Hefei, China. keli_kl@163.com.
- Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450052, China. fccguzy@zzu.edu.cn.
Förderung
- Anhui Chest Hospital Institutional Research Projects
- National Natural Science Foundation of China
- Cultivation Project of Henan Health Science and Technology Innovation Talents
Zitieren
APA
Cheng, X., Zhu, D., Guo, H., Zheng, T., Wu, B., Sheng, Y., Li, F., Sun, G., Zhao, S., Ke, L., & Gu, Z. (2026). Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05031-3
Vancouver
Cheng X, Zhu D, Guo H, Zheng T, Wu B, Sheng Y, et al. Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05031-3
BibTeX
@article{Cheng2026,
author = {Cheng, Xingdong and Zhu, Dengyan and Guo, Haizhou and Zheng, Tianliang and Wu, Bin and Sheng, Yinliang and Li, Feng and Sun, Guangcheng and Zhao, Song and Ke, Li and Gu, Zhuoyu},
title = {Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05031-3}
}
EUVIMED